Reuters logo
8 months ago
BRIEF-Redhill Biopharma says positive DSMB recommendation for continuation of RHB-104 Phase III study
December 13, 2016 / 1:47 PM / 8 months ago

BRIEF-Redhill Biopharma says positive DSMB recommendation for continuation of RHB-104 Phase III study

Dec 13 (Reuters) - Redhill Biopharma Ltd

* Redhill Biopharma announces positive and unanimous DSMB recommendation for continuation of Phase III study with RHB-104 for Crohn's disease

* Second independent DSMB meeting is expected in Q2 of 2017 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below